Menu
Recruiting NCT06423963

Remote Exercise and Nutritional Prehabilitation for Pancreatic Cancer

No phase Interventional Pancreatic Cancer

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Physical Activity, Nutrition Counseling, Resistance Training.
Who it may be relevant to
Registry conditions: Pancreatic Cancer. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

The purpose of the study is to examine the feasibility and acceptability of an exercise and nutrition "prehabilitation" program for patients preparing for pancreatic cancer resection (removal).

Interventions

  • Behavioral Physical Activity
    Each participant will receive a Fitbit device with instruction and encouragement to self-monitor physical activity using step counts.
  • Behavioral Nutrition Counseling
    Participants will receive nutritional counseling with a registered dietician.
  • Behavioral Resistance Training
    Participants will engage in progressive, full-body resistance training based on American College of Sports Medicine (ACSM) guidelines.

Primary outcome measures

  • Feasibility and acceptability of PA/N and RT/N programs [Time frame: Up to 16 weeks]
Secondary outcome measures (2)
  • Examine exploratory outcomes and clinical characteristics [Time frame: Up to 16 weeks]
  • Compare clinical and treatment outcomes [Time frame: Up to 16 weeks]

Eligibility criteria

Inclusion criteria

  • Age 18 years or older
  • Biopsy-proven pancreatic ductal adenocarcinoma (PDAC), borderline resectable at diagnosis
  • Eastern Cooperative Oncology Group (ECOG) performance status 0-2
  • Undergoing neoadjuvant chemotherapy with treatment plan including chemoradiation therapy and surgical resection
  • Ability to read and speak English

Exclusion criteria

  • Regular engagement in RT (2x/week targeting all major muscle groups)
  • Screen failure for exercise safety based on PAR-Q
  • Underlying unstable cardiac or pulmonary disease or symptomatic cardiac disease
  • Recent fracture or acute musculoskeletal injury that precludes ability to participate in RT
  • Numeric pain rating scale greater than or equal to a 7 out of 10
  • Myopathic or rheumatologic disease that impacts physical function

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Supportive care

Study locations

United States · 1 center
  • Moffitt Cancer Center — Tampa

Identifiers

NCT: NCT06423963 · MCC-23088

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗